 | Study programme 2025-2026 | Français | |
| Pharmacovigilance | |||
Learning Activity |
| Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
|---|---|---|---|---|
| M-DOYM-226 |
|
|
| Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
|---|---|---|---|---|---|---|---|
| Français | Français | 10 | 0 | 0 | 0 | 0 | Q1 |
Content of Learning Activity
The roles and warnings of the FAMHP regarding the proper use of health products.
Development of the multiple objectives of pharmacovigilance in the context of the management of a patient and his medication.
The role of the PRAC (Pharmacovigilance Risk Assessment Committee)
Or find reliable and compliant validated information
Understand the correct interpretation of the concepts of enhanced vigilance and the notions of risk minimization of pharmac activities.
The primary role of healthcare professionals in adverse reaction reporting.
Reading and presentation of the VigNews, presentation of EufraVigilance and the Vigilyze.
Understand how adverse reactions are reported.
Understand the importance of a pharmacovigilance signal, identify the three sources of this signal (AR reporting, clinical studies, and scientific literature).
Faced with a pharmacovigilance problem, it is better to act than to react.
Required Learning Resources/Tools
Power point available to students
Recommended Learning Resources/Tools
No information
Other Recommended Reading
Jamila Hamdani: Pharmacovigilance: au delà des émotions, comment gérer l'incertitude - YouTube
Publications scientifiques | AFMPS
Mode of delivery
- Face-to-face
Type of Teaching Activity/Activities
- Cours magistraux
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)
Location of learning activity
- Université de Mons - Mons
Location of assessment
- Université de Mons - Mons